OssDsign Catalyst Shows 0% Device-related Complication Rate

OssDsign Catalyst Bone Substitute

Data from the first postmarket safety report of OssDsign's OssDsign Catalyst revealed that, from product launch in August 2021 through August 2022, the product did not record any device related complaints nor device related adverse events.

OssDsign Catalyst is a nanosynthetic bone graft that stimulates the formation of healthy bone tissue in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us